Month: September 2025
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Royal Road Minerals Limited (TSXV: RYR; OTCQB: RRDMF) (“Royal Road” or the “Company”) and Rio2 Limited (TSX: RIO; OTCQX: RIOFF; BVL: RIO) (“Rio2”) are pleased to jointly announce that Rio2 has acquired 39,855,000 ordinary shares of Royal Road (“Shares”) representing approximately 15.0% of Royal Road’s issued and outstanding Shares and has become an “insider” of the Company under applicable securities laws and the policies of the TSX Venture Exchange (“TSXV”).
The acquisition formed part of a block trade on the TSX Venture Exchange, transferring the entire shareholding previously held by a single investor to Rio2 and other institutional investors known to both parties.
“We are genuinely delighted to welcome Rio2, under the leadership of Alex Black and Andrew Cox, as our new shareholders...
Asante Announces Start of Bibiani Sulphide Plant Operation
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Sept. 29, 2025 (GLOBE NEWSWIRE) — Asante Gold Corporation (TSXV:ASE | GSE:ASG OTCQX:ASGOF) (“Asante” or the “Company”), an emerging mid-tier gold producer, is pleased to provide an update on progress made on its sulphide plant at the Bibiani Gold Mine (“Bibiani Mine” and “Bibiani”), in the republic of Ghana.
Recent Highlights:Health and safety: Lost Time Incident Frequency Rate of 0.00, and Total Recordable Incident Frequency Rate of 0.00 for year-to-date 2025
Project Cost: Total spent to date of US$32M versus US$32M budgeted (pre-tax)
Status: Construction and commissioning are complete12 h/d operation to process Bibiani ore started on September 27, 2025
24 h/d operation expected to start on September 30, 2025 and optimization to achieve +85% gold recovery will progress through October 2025Bibiani...
Novartis announces commencement of tender offer to acquire Tourmaline Bio
Written by Customer Service on . Posted in Mergers And Acquisitions.
Basel, September 29, 2025 – Novartis today announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to acquire all of the outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline Bio, Inc., a Delaware corporation (“Tourmaline”), at a price of $48 per Share, in cash, without interest and subject to any applicable withholding. Such offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated September 29, 2025, and the related Letter of Transmittal (together, the “Offer”) and pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of September 8, 2025 (the “Merger Agreement”), among Novartis, Purchaser and Tourmaline.
The...
Amplify ETFs Declares September Income Distributions for its Income ETFs
Written by Customer Service on . Posted in Dividend Reports And Estimates.
CHICAGO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Amplify ETFs announces September income distributions for its income ETFs.ETF Name
Ticker
Amount per Share
Ex-Date
Record Date
Payable DateAmplify Bitcoin Max Income Covered Call ETF
BAGY
$1.53000
9/29/25
9/29/25
9/30/25Amplify Bitcoin 2% Monthly Option Income ETF
BITY
$1.09700
9/29/25
9/29/25
9/30/25Amplify SILJ Covered Call ETF
SLJY
$0.48366
9/29/25
9/29/25
9/30/25Amplify Samsung SOFR ETF
SOFR
$0.36238
9/29/25
9/29/25
9/30/25Amplify CWP Growth & Income ETF
QDVO
$0.29060
9/29/25
9/29/25
9/30/25Amplify COWS Covered Call ETF
HCOW
$0.24160
9/29/25
9/29/25
9/30/25Amplify Bloomberg U.S. Treasury 12% Premium Income ETF
TLTP
$0.22740
9/29/25
9/29/25
9/30/25Amplify CWP International Enhanced Dividend Income ETF
IDVO
$0.18550
9/29/25
9/29/25
9/30/25Amplify CWP...
Costamare Bulkers Holdings Limited Announces Strategic Cooperation Agreement with Cargill International SA
Written by Customer Service on . Posted in Public Companies.
MONACO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (“Costamare Bulkers” or the “Company”) (NYSE: CMDB) announced today that it has signed a Strategic Cooperation Agreement (the “Agreement”) with Cargill International S.A. (“Cargill”).
Under the Agreement, the Company has agreed to:Transfer to Cargill the majority of its trading book comprising of chartered-in vessels, cargo transportation commitments as well as derivative positions;
Charter to Cargill four Supramax vessels for a period of four to six months;
Enter into a bunkering services agreement with Seascale Energy (a joint venture between Cargill and Hafnia), covering the owned and operating fleet;
Enter into an agreement in respect of decarbonisation and vessel efficiency strategies and implementing decarbonisation projects;
Explore opportunities...
Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company’s Dedication to Improving the Lives of Cancer Patients
Written by Customer Service on . Posted in Public Companies.
-A first-in-class LRP1 agonist, SP16 phase 1b Chemotherapy Induced Neuropathy (CIPN) Study fully funded by the National Cancer Institute, with projected patient enrollment beginning in the first half of 2026-
–SP16 has demonstrated both anti-inflammatory and neural repair activity that has the potential to treat CIPN, synergistically complementing Halneuron®, the Company’s late stage NaV1.7 inhibitor, which has demonstrated significant pain reduction in previous Phase 2 studies-
-Webcast today, September 29, 2025, at 8:30 a.m. Eastern Time-
ATLANTA, Sept. 29, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and neuropathy, today announced that in an all-stock transaction, it has secured a royalty free,...
NOVONIX Achieves Critical Operational Milestone
Written by Customer Service on . Posted in Public Companies.
Commercial-grade sampleFirst mass production, industrial-grade sample of synthetic graphite.NOVONIX Riverside FacilityNOVONIX’s Riverside facility in Chattanooga, Tennessee, poised to become the first large-scale production site dedicated to high-performance synthetic graphite for the battery, defense, and industrial sectors in North America.CHATTANOOGA, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, announced today the delivery of its first mass production, commercial-grade sample of synthetic graphite for industrial applications to one of North America’s largest value-added carbon processors with a global market reach.
“We’re pleased to have hit this significant manufacturing milestone,”...
Enlight Secures Nearly $340 Million in Tax Equity Partnerships for Roadrunner Solar and Energy Storage Project
Written by Customer Service on . Posted in Public Companies.
Roadrunner signs two separate tax equity partnerships: J.P. Morgan for solar, and M&T Bank together with First Citizens Bank, for energy storage
Roadrunner, a 290 MW solar and 940 MWh storage project in Arizona, has initiated production of test energy and is expected to reach full COD by the end of 2025
Enlight strengthens its U.S. growth strategy, collaborating with new financing partners to support a robust project pipeline across leading power markets
TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — Enlight Renewable Energy (TASE&NASDAQ: ENLT), a leading global renewable energy company, announced today that its U.S. subsidiary Clēnera Holdings has closed two tax equity partnership agreements for the Roadrunner Solar and Energy Storage Project, located near Tucson, Arizona.
The first agreement, with J.P. Morgan Chase...
MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer
Written by Customer Service on . Posted in Public Companies.
MannKind CMOMannKind appoints Dr. Ajay Ahuja as EVP, Chief Medical OfficerWESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, today announced the appointment of Ajay Ahuja, MD, MBA, as Chief Medical Officer, effective today. Dr. Ahuja will report directly to Michael Castagna, PharmD, Chief Executive Officer, and will serve on the company’s executive leadership team.
“Ajay’s deep expertise in medical affairs, clinical development, and global strategy—combined with his background as a practicing physician—will be instrumental as we continue to advance our pipeline and expand our impact in endocrine and orphan lung...
USA Rare Earth Accelerates Mine-to-Magnet Strategy with the Transformative Acquisition of Less Common Metals (LCM)
Written by Customer Service on . Posted in Mergers And Acquisitions.
Establishes USAR as the Leading Scaled Rare Earth Metal and Alloy Manufacturer Outside of China with Leadership in Samarium, Samarium Cobalt and Neodymium Praseodymium Metals and Alloys
Secures Critical Link in USAR’s Supply Chain by Providing Rare Earth Metal and Strip Cast Alloy Capability and Ability to Make Metal from Recycled Rare Earth Oxides
Creates Unique Competitive Advantage and Accelerates USAR’s Revenue Generation Ability
Significant Revenue Synergies Provided by Access to an Expanded Global Customer Base, Important Supply Chain Relationships and Allied Governments
$125 Million Common Stock Equity Investment from Existing Shareholder Provides Capital to Expedite Growth Plans
USAR to Host Conference Call at 8:30am ET
STILLWATER, Okla., Sept. 29, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the...
